MPW vs SBRA

For growth investors, Sabra Health Care REIT, Inc.

(SBRA) is the stronger pick with 10. 2% revenue growth year-over-year, versus -2. 4% for Medical Properties Trust, Inc. (MPW). Sabra Health Care REIT, Inc. (SBRA) offers the better valuation at 32. 0x trailing P/E (29. 7x forward), making it the more compelling value choice. Analysts rate Medical Properties Trust, Inc. (MPW) a "Hold" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Sabra Health Care REIT, Inc.

is actually cheaper at 29. 7x.

Over the past 5 years, Sabra Health Care REIT, Inc.

(SBRA) delivered a total return of +52. 4%, compared to -55. 6% for Medical Properties Trust, Inc. (MPW). Over 10 years, the gap is even starker: SBRA returned +54. 1% versus MPW's +0. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Sabra Health Care REIT, Inc.

(SBRA) is the lower-risk stock at -0. 06β versus Medical Properties Trust, Inc. 's 0. 30β — meaning MPW is approximately -567% more volatile than SBRA relative to the S&P 500. On balance sheet safety, Medical Properties Trust, Inc. (MPW) carries a lower debt/equity ratio of 3% versus 90% for Sabra Health Care REIT, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sabra Health Care REIT, Inc.

(SBRA) is pulling ahead at 10. 2% versus -2. 4% for Medical Properties Trust, Inc. (MPW). On earnings-per-share growth, the picture is similar: Medical Properties Trust, Inc. grew EPS 91. 8% year-over-year, compared to 18. 5% for Sabra Health Care REIT, Inc.. Over a 3-year CAGR, SBRA leads at 7. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Sabra Health Care REIT, Inc.

(SBRA) is the more profitable company, earning 20. 1% net margin versus -20. 4% for Medical Properties Trust, Inc. — meaning it keeps 20. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MPW leads at 38. 1% versus 34. 1% for SBRA. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Sabra Health Care REIT, Inc.

(SBRA) trades at 29. 7x forward P/E versus 49. 4x for Medical Properties Trust, Inc. — 19. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SBRA: 3. 4% to $21. 20.

In this comparison, SBRA (5.

8% yield) pays a dividend. MPW does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Sabra Health Care REIT, Inc.

(SBRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 06), 5. 8% yield). Both have compounded well over 10 years (SBRA: +54. 1%, MPW: +0. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: MPW is a small-cap quality compounder stock; SBRA is a small-cap income-oriented stock. SBRA pays a dividend while MPW does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.